ATE377657T1 - Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung - Google Patents

Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung

Info

Publication number
ATE377657T1
ATE377657T1 AT02717374T AT02717374T ATE377657T1 AT E377657 T1 ATE377657 T1 AT E377657T1 AT 02717374 T AT02717374 T AT 02717374T AT 02717374 T AT02717374 T AT 02717374T AT E377657 T1 ATE377657 T1 AT E377657T1
Authority
AT
Austria
Prior art keywords
hiv infection
serpine
drugs
prevention
treating hiv
Prior art date
Application number
AT02717374T
Other languages
English (en)
Inventor
Ralf Lynn
Bruce Walker
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE377657T1 publication Critical patent/ATE377657T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02717374T 2001-01-26 2002-01-25 Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung ATE377657T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26433801P 2001-01-26 2001-01-26

Publications (1)

Publication Number Publication Date
ATE377657T1 true ATE377657T1 (de) 2007-11-15

Family

ID=23005599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02717374T ATE377657T1 (de) 2001-01-26 2002-01-25 Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung

Country Status (7)

Country Link
US (2) US20020127698A1 (de)
EP (1) EP1362127B1 (de)
AT (1) ATE377657T1 (de)
AU (1) AU2002248384A1 (de)
DE (1) DE60223340T2 (de)
ES (1) ES2296914T3 (de)
WO (1) WO2002058638A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10045047A1 (de) 2000-09-12 2002-03-21 Beate Kehrel Arzneimittel enthaltend aktiviertes Antithrombin III
US20110008889A1 (en) * 2001-01-26 2011-01-13 Ralf Geiben-Lynn Serpin drugs for treatment of hiv infection and method of use thereof
US7326692B2 (en) * 2001-11-14 2008-02-05 The University Of Chicago Induction of immunity using inhibitors of granzymes
US9661519B2 (en) 2003-02-24 2017-05-23 Qualcomm Incorporated Efficient reporting of information in a wireless communication system
US7218948B2 (en) * 2003-02-24 2007-05-15 Qualcomm Incorporated Method of transmitting pilot tones in a multi-sector cell, including null pilot tones, for generating channel quality indicators
US9544860B2 (en) * 2003-02-24 2017-01-10 Qualcomm Incorporated Pilot signals for use in multi-sector cells
US8811348B2 (en) * 2003-02-24 2014-08-19 Qualcomm Incorporated Methods and apparatus for generating, communicating, and/or using information relating to self-noise
US7498130B2 (en) 2003-05-13 2009-03-03 Massachusetts General Hospital Method of reducing viral load
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
WO2006014519A1 (en) * 2004-07-07 2006-02-09 The General Hospital Corporation Direct activation of atiii in whole blood and plasma
US20060092881A1 (en) * 2004-10-14 2006-05-04 Rajiv Laroia Methods and apparatus for determining, communicating and using information which can be used for interference control purposes
RU2007117711A (ru) * 2004-10-14 2008-11-20 Квэлкомм Флэрион Текнолоджиз, Инк. (Us) Способы и устройство для определения, передачи и использования информации, которая может быть использована для целей управления помехами
US8503938B2 (en) * 2004-10-14 2013-08-06 Qualcomm Incorporated Methods and apparatus for determining, communicating and using information including loading factors which can be used for interference control purposes
SG158919A1 (en) 2005-01-24 2010-02-26 Univ Texas Constructs binding to phosphatidylserine and their use in disease treatment
US8989084B2 (en) 2005-10-14 2015-03-24 Qualcomm Incorporated Methods and apparatus for broadcasting loading information corresponding to neighboring base stations
US9191840B2 (en) * 2005-10-14 2015-11-17 Qualcomm Incorporated Methods and apparatus for determining, communicating and using information which can be used for interference control
US20090227518A1 (en) * 2005-12-02 2009-09-10 The Regents Of The University Of Colorado Compositions and methods for treating actin-mediated medical conditions
US9125093B2 (en) * 2005-12-22 2015-09-01 Qualcomm Incorporated Methods and apparatus related to custom control channel reporting formats
US20070253449A1 (en) * 2005-12-22 2007-11-01 Arnab Das Methods and apparatus related to determining, communicating, and/or using delay information
US9125092B2 (en) 2005-12-22 2015-09-01 Qualcomm Incorporated Methods and apparatus for reporting and/or using control information
US9119220B2 (en) * 2005-12-22 2015-08-25 Qualcomm Incorporated Methods and apparatus for communicating backlog related information
US8514771B2 (en) * 2005-12-22 2013-08-20 Qualcomm Incorporated Methods and apparatus for communicating and/or using transmission power information
US9137072B2 (en) * 2005-12-22 2015-09-15 Qualcomm Incorporated Methods and apparatus for communicating control information
US9148795B2 (en) * 2005-12-22 2015-09-29 Qualcomm Incorporated Methods and apparatus for flexible reporting of control information
US9338767B2 (en) 2005-12-22 2016-05-10 Qualcomm Incorporated Methods and apparatus of implementing and/or using a dedicated control channel
US9451491B2 (en) * 2005-12-22 2016-09-20 Qualcomm Incorporated Methods and apparatus relating to generating and transmitting initial and additional control information report sets in a wireless system
US9572179B2 (en) 2005-12-22 2017-02-14 Qualcomm Incorporated Methods and apparatus for communicating transmission backlog information
US8437251B2 (en) 2005-12-22 2013-05-07 Qualcomm Incorporated Methods and apparatus for communicating transmission backlog information
US20070149132A1 (en) 2005-12-22 2007-06-28 Junyl Li Methods and apparatus related to selecting control channel reporting formats
US9473265B2 (en) 2005-12-22 2016-10-18 Qualcomm Incorporated Methods and apparatus for communicating information utilizing a plurality of dictionaries
US20070243882A1 (en) * 2006-04-12 2007-10-18 Qualcomm Incorporated Method and apparatus for locating a wireless local area network associated with a wireless wide area network
EP2616487B1 (de) * 2010-09-14 2015-03-25 F.Hoffmann-La Roche Ag Serpin-finger-fusionspolypeptid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
ATE12779T1 (de) * 1980-09-30 1985-05-15 Bayer Ag Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
GB2116183B (en) 1982-03-03 1985-06-05 Genentech Inc Human antithrombin iii dna sequences therefore expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby a process for expressing human antithrombin iii and pharmaceutical compositions comprising it
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
CA1341379C (en) 1988-04-28 2002-07-23 Welfide Corporation Purified antithrombin-iii and methods of producing the same
US5610286A (en) 1991-11-04 1997-03-11 The Regents Of The University Of California DNA's encoding natural killer cell enhancing factor
US5376633A (en) * 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
AU3479495A (en) 1994-09-30 1996-04-26 Ppl Therapeutics (Scotland) Ltd Alpha-1-antitrypsin and antithrombine-iii variants
WO1996039424A1 (en) 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Natural killer cell enhancing factor c
WO2000052034A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections

Also Published As

Publication number Publication date
EP1362127A4 (de) 2004-09-22
WO2002058638A3 (en) 2002-09-26
ES2296914T3 (es) 2008-05-01
US20020127698A1 (en) 2002-09-12
WO2002058638A2 (en) 2002-08-01
DE60223340T2 (de) 2008-08-28
DE60223340D1 (de) 2007-12-20
US20050058637A1 (en) 2005-03-17
EP1362127B1 (de) 2007-11-07
US7510828B2 (en) 2009-03-31
EP1362127A2 (de) 2003-11-19
AU2002248384A1 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
ATE377657T1 (de) Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung
DE60229059D1 (de) Proteomimetische verbindungen und verfahren
EP1385476A4 (de) Verfahren zur diagnostizierung und behandlung von bakterienwucherung im dünndarum (sibo) und damit zusammenhängenden erkrankungen
ATE463294T1 (de) Verfahren zur konzentration und reinigung von biologischen verbindungen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE69939312D1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
CY1111263T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει sns-595 και χρησεις αυτης
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
ATE173544T1 (de) Parvovirusrezeptoren und verfahren zur ihrer verwendung
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE112004000961D2 (de) Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
FI20011664A7 (fi) Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
ATE412666T1 (de) Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
EP1468005A4 (de) Verfahren zur verwendung von konjugaten von sacchariden und acetamidino- oder guanidinoverbindungen zur behandlung von bakteriellen infektionen
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
ATE425187T1 (de) Materialien und methoden zur behandlung von hepatitis c
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
EP1370697A4 (de) Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion und verfahren zu deren verwendung
DE60013326D1 (de) Verbindungen und verfahren zur behandlung von schmerz
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
EP1549672A4 (de) Von ablatiertem slam abhängiger eintritt

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1362127

Country of ref document: EP

REN Ceased due to non-payment of the annual fee